Douglas Daoudlarian

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Nature communications

Translational psychiatry

Nature biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Guiseppe Pantaleo, Michel Obeid
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature communications 15 (1) (2024)
Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Guiseppe Pantaleo, Michel Obeid
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature communications 15 (1) (2024)
Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Guiseppe Pantaleo, Michel Obeid
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature communications 15 (1) (2024)
Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Guiseppe Pantaleo, Michel Obeid
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature communications 15 (1) (2024)
Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Guiseppe Pantaleo, Michel Obeid
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature communications 15 (1) (2024)
Emanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, Wafa Bel Haj Ali, Cyprien Gilet, Lionel Fillatre, Olfa Khalfallah, Réjane Troudet, Stéphane Jamain, Guillaume Fond, Iris Sommer, Stefan Leucht, Paola Dazzan, Philip McGuire, Celso Arango, Covadonga M Diaz-Caneja, Wolfgang Fleischhacker, Dan Rujescu, Birte Glenthøj, Inge Winter, René Sylvain Kahn, Robert Yolken, Shon Lewis, Richard James Drake, Laetitia Davidovic, Marion Leboyer, Nicolas Glaichenhaus, null null
Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study. Translational psychiatry 9 (1) (2019)
Emanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, Wafa Bel Haj Ali, Cyprien Gilet, Lionel Fillatre, Olfa Khalfallah, Réjane Troudet, Stéphane Jamain, Guillaume Fond, Iris Sommer, Stefan Leucht, Paola Dazzan, Philip McGuire, Celso Arango, Covadonga M Diaz-Caneja, Wolfgang Fleischhacker, Dan Rujescu, Birte Glenthøj, Inge Winter, René Sylvain Kahn, Robert Yolken, Shon Lewis, Richard James Drake, Laetitia Davidovic, Marion Leboyer, Nicolas Glaichenhaus, null null
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study. Translational psychiatry 9 (1) (2019)
Mélanie Guyot, Thomas Simon, Franck Ceppo, Clara Panzolini, Alice Guyon, Julien Lavergne, Emilie Murris, Douglas Daoudlarian, Romain Brusini, Hadi Zarif, Sophie Abélanet, Sandrine Hugues-Ascery, Jean-Louis Divoux, Stephen J Lewis, Arun Sridhar, Nicolas Glaichenhaus, Philippe Blancou
Pancreatic nerve electrostimulation inhibits recent-onset autoimmune diabetes. Nature biotechnology 37 (12) (2019)

Douglas Daoudlarian.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Douglas Daoudlarian